Epidermolysis Bullosa Clinical Trials Near Me
As of October 12, 2026, 27 Epidermolysis Bullosa clinical trials are recruiting or about to open (21 recruiting now, 6 opening soon). 15 of them have at least 1 open site in the United States, across 11 states. Enter your ZIP code to see which are closest to you.
Also on Trial Friend:Epidermolysis Bullosa pageMatch Me
All 21 Epidermolysis Bullosa trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving FilsuvezLucile Packard Children's Hospital, Palo Alto, California; UCHealth / Children's Hospital Colorado, Aurora, Colorado; UF College of Medicine, Gainesville, Florida and 3 more sitesRecruitingRun by Chiesi Farmaceutici S.p.A.
- A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis BullosaMission Dermatology Center, Rancho Santa Margarita, California; Skin Research Institute, Coral Gables, Florida; UMass Memorial Medical Center, Worcester, Massachusetts and 2 more sitesRecruitingPhase 3Ages 6 Months+Run by Krystal Biotech, Inc.
- A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing SettingLucile Packard Children's Hospital, Palo Alto, California; Children's Hospital Colorado, Aurora, Colorado; Ann & Robert H. Lurie Children's Hospital of Chicago - Department of Dermatology, Chicago, Illinois and 1 more siteRecruitingRun by Abeona Therapeutics, Inc
- Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis BullosaMission Dermatology, Rancho Santa Margarita, California; Stanford University School of Medicine Dermatology Department, Redwood City, California; Medical University of South Carolina Department of Dermatology and Dermatologic Surgery, Charleston, South CarolinaRecruitingPhase 3Ages 28 Days to 12Run by Paradigm Therapeutics
- Long-Term Follow-up ProtocolMission Dermatology Center, Rancho Santa Margarita, California; Stanford University, Redwood City, California; Pediatric Skin Research, Coral Gables, FloridaRecruitingAges 6 Months+Run by Krystal Biotech, Inc.
- MSC EVs in Dystrophic Epidermolysis BullosaPhoenix Children's Hospital, Phoenix, Arizona; USC /Norris Comprehensive Cancer Center University of Southern California, Los Angeles, California; Children's Hospital of Philadelphia, Philadelphia, PennsylvaniaRecruitingPhase 1/2Ages 6 Months+Run by Aegle Therapeutics
- A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa SimplexStanford University School of Medicine, Dermatology Department, Palo Alto, California; NU Dermatolgy CTU, Chicago, IllinoisRecruitingPhase 2Ages 2+Run by BioMendics, LLC
- A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)Krystal Biotech, Pittsburgh, PennsylvaniaRecruitingAges 6 Months+Run by Krystal Biotech, Inc.
- A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-studyCincinnati Children's Hospital Medical Center, Cincinnati, OhioRecruitingPhase 2Ages 4+Run by Xinnate AB
- Characteristics of Patients With Recessive Dystrophic Epidermolysis BullosaStanford University School of Medicine, Stanford, CaliforniaRecruitingRun by Stanford University
- Gentamicin for Junctional Epidermolysis BullosaUniversity of Southern California, Los Angeles, CaliforniaRecruitingPhase 1/2Run by University of Southern California
- Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus PositionsCharlotte R. Bloomberg Children's Center, Baltimore, MarylandRecruitingAges 5 to 21Run by Johns Hopkins University
- Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis BullosaStanford University, Redwood City, CaliforniaRecruitingPhase 1/2Ages 6+Run by M. Peter Marinkovich
- A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex GeneralizedNo open US site listed yetRecruitingPhase 2Ages 6 to 99Run by Centre Hospitalier Universitaire de Nice
- A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory GenodermatosesNo open US site listed yetRecruitingPhase 2Ages 18 to 99Run by Centre Hospitalier Universitaire de Nice
- A Study to Evaluate ENERGI-F703EB Cream in Epidermolysis BullosaNo open US site listed yetRecruitingPhase 2Ages 18+Run by Energenesis Biomedical Co., Ltd.
- A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis BullosaNo open US site listed yetRecruitingPhase 3Ages 21 Days+Run by Chiesi Farmaceutici S.p.A.
- Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis BullosaNo open US site listed yetRecruitingPhase 1/2Ages 3 to 35Run by Isfahan University of Medical Sciences
- FARD (RaDiCo Cohort) (RaDiCo-FARD)No open US site listed yetRecruitingRun by Institut National de la Santé Et de la Recherche Médicale, France
- GMEB-SASS: A Gene-Modified Skin Substitute for RDEB TreatmentNo open US site listed yetRecruitingPhase 1/2Ages 7+Run by CHU de Quebec-Universite Laval
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Epidermolysis Bullosa. Turn any of these off from the link in every email.
Where Epidermolysis Bullosa trials are recruiting in the US
The US cities with the most Epidermolysis Bullosa trials recruiting are Palo Alto, California (4), Redwood City, California (4), Cincinnati, Ohio (3), Rancho Santa Margarita, California (3) and Aurora, Colorado (2), counting trials with at least 1 open site in each city.
Hospitals that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Epidermolysis Bullosa, even if no trial fits you.
- Lucile Packard Children's Hospital
- Stanford University School of Medicine
- Stanford University School of Medicine, Dermatology Department
- Stanford University
- Stanford University School of Medicine Dermatology Department
- Cincinnati Children's Hospital Medical Center
- Cincinnati Children's
- Mission Dermatology Center
- Mission Dermatology
- Children's Hospital Colorado
- UCHealth / Children's Hospital Colorado
- Medical University of South Carolina
- Medical University of South Carolina Department of Dermatology and Dermatologic Surgery
- Ann & Robert H. Lurie Children's Hospital of Chicago - Department of Dermatology
- NU Dermatolgy CTU
- Pediatric Skin Research
- Skin Research Institute
States with at least 1 open site: Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, Ohio, Pennsylvania, South Carolina, Texas.
Questions about finding an Epidermolysis Bullosa trial near you
Are there Epidermolysis Bullosa clinical trials near me?
As of October 12, 2026, 27 Epidermolysis Bullosa clinical trials are recruiting or about to open (21 recruiting now, 6 opening soon). 15 of them have at least 1 open site in the United States, across 11 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Epidermolysis Bullosa clinical trial sites?
As of October 12, 2026, recruiting Epidermolysis Bullosa trials list open sites in Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, Ohio, Pennsylvania, South Carolina and Texas.
What if there is no Epidermolysis Bullosa trial near me?
Some trials pay for or reimburse travel and lodging, and a few send staff or use local labs so fewer visits happen at the study site, so ask the study contact before ruling a trial out. You can also sign up on this page to get an email when an Epidermolysis Bullosa trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Epidermolysis Bullosa: Vyjuvek (beremagene geperpavec-svdt), Zevaskyn (prademagene zamikeracel), Filsuvez (birch triterpenes).
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of October 12, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out.